Articles

1. Hepatic estrogen and progesterone receptors in an estrogen-associated hepatic neoplasm

   • J. S. Macdonald
   • M. E. Lippman
   • P. S. Schein

   Original Papers Pages: 135 - 138

2. Assessment of host defence against infection during chemotherapy of Hodgkin's disease

   • I. Addison
   • Jane Babbage
   • R. Souhami

   Original Papers Pages: 129 - 133

3. The clinical evaluation of analogues

   • S. K. Carter

   General Review Pages: 123 - 128

4. Prognosis and treatment of acute lymphoblastic leukemia

   • C. Jacquillat
   • M. Weil
   • J. Bernard

   Original Papers Pages: 113 - 122

5. Combination chemotherapy for advanced non-Hodgkin's lymphoma of unfavourable histology

   • T. A. Lister
   • M. H. Cullen
   • D. Crowther

   Original Papers Pages: 107 - 112

6. Initial clinical experience with a simultaneous combination of 2,4-diamino-5(3′,4′-dichlorophenyl)-6-methylpyrimidine (DDMP) with folinic acid

   • Pierre Alberto
   • Renate Peytremann
   • Mario Beretta-Piccoli

   Original Papers Pages: 101 - 105

7. New natural products of interest under development at the National Cancer Institute

   • John Douros
   • Matthew Suffness

   Original Papers Pages: 91 - 100

8. The role of antitumor antibiotics in current oncologic practice

   • Hugh L. Davis Jr.
   • Daniel D. von Hoff
   • Marcel Rozencweig

   Short Review Pages: 83 - 90

9. The fluoropyrimidines: Biochemical mechanisms and design of clinical trials

   • Michael A. Friedman
   • Wolfgang Sadée

   Short Review Pages: 77 - 82

10. Mitomycin C: Experience in the United States, with emphasis on gastric cancer

    • Philip S. Schein
    • John S. Macdonald
    • Paul V. Wooley

    Short Review Pages: 73 - 75

11. The clinical evaluation of analogues

    • Stephen K. Carter

    Editorial Pages: 69 - 72

12. Chemotherapy, a double agent in respect of immune functions

    • G. Mathé

    Editorial Pages: 65 - 68

13. Pharmacokinetic and clinical studies of 24-h infusions of high-dose methotrexate

    • Harvey J. Cohen
    • Norman Jaffe

    Original Papers Pages: 61 - 64

14. Combined chemotherapy-radiotherapy approach in locally advanced (T_3b-T₄) breast cancer

    • Mario De Lena
    • Roberto Zucali
    • Gianni Bonadonna

    Original Papers Pages: 53 - 59

15. In vivo toxicity to lymphoid tissue by 2′-Deoxycoformycin

    • John F. Smyth
    • Robert C. Young
    • David M. Young

    Original Papers Pages: 49 - 51

16. Correlations between experimental chemotherapy in the murine glioma and effectiveness of clinical therapy regimens

    • Victor A. Levin
    • Charles B. Wilson

    Original Papers Pages: 41 - 48

17. Sequential combination chemotherapy in advanced breast cancer

    • Cristina Brambilla
    • Pinuccia Valagussa
    • Gianni Bonadonna

    Original Papers Pages: 35 - 39

18. Cardiotoxic effects of antitumor agents

    • Mario Ghione

    Short Review Pages: 25 - 34

19. New drugs under clinical evaluation in the United States

    • Stephen K. Carter

    Short Review Pages: 15 - 24

20. New cancer chemotherapy drugs in Europe

    • G. Mathé
    • L. M. van Putten

    Short Review Pages: 5 - 13

21. Cancer chemotherapy as it approaches middle age

    • Stephen K. Carter

    Editorial Pages: 1 - 4